Allison JP - Search Results

1

CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells.

Quezada SA, Peggs KS, Curran MA, Allison JP. Quezada SA, et al. Among authors: allison jp. J Clin Invest. 2006 Jul;116(7):1935-45. doi: 10.1172/JCI27745. Epub 2006 Jun 15. J Clin Invest. 2006. PMID: 16778987 Free PMC article.

2

Enhancement of antitumor immunity by CTLA-4 blockade.

Leach DR, Krummel MF, Allison JP. Leach DR, et al. Among authors: allison jp. Science. 1996 Mar 22;271(5256):1734-6. doi: 10.1126/science.271.5256.1734. Science. 1996. PMID: 8596936

3

Lymphocyte activation and effector functions. How signals are integrated in the immune system.

Nussenzweig M, Allison JP. Nussenzweig M, et al. Among authors: allison jp. Curr Opin Immunol. 1997 Jun;9(3):293-5. doi: 10.1016/s0952-7915(97)80073-8. Curr Opin Immunol. 1997. PMID: 9203423 Review. No abstract available.

4

Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer.

Kwon ED, Hurwitz AA, Foster BA, Madias C, Feldhaus AL, Greenberg NM, Burg MB, Allison JP. Kwon ED, et al. Among authors: allison jp. Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8099-103. doi: 10.1073/pnas.94.15.8099. Proc Natl Acad Sci U S A. 1997. PMID: 9223321 Free PMC article.

5

Thymocyte development is normal in CTLA-4-deficient mice.

Chambers CA, Cado D, Truong T, Allison JP. Chambers CA, et al. Among authors: allison jp. Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9296-301. doi: 10.1073/pnas.94.17.9296. Proc Natl Acad Sci U S A. 1997. PMID: 9256476 Free PMC article.

6

Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells.

Chambers CA, Sullivan TJ, Allison JP. Chambers CA, et al. Among authors: allison jp. Immunity. 1997 Dec;7(6):885-95. doi: 10.1016/s1074-7613(00)80406-9. Immunity. 1997. PMID: 9430233

7

Repression of B7.2 on self-reactive B cells is essential to prevent proliferation and allow Fas-mediated deletion by CD4(+) T cells.

Rathmell JC, Fournier S, Weintraub BC, Allison JP, Goodnow CC. Rathmell JC, et al. Among authors: allison jp. J Exp Med. 1998 Aug 17;188(4):651-9. doi: 10.1084/jem.188.4.651. J Exp Med. 1998. PMID: 9705947 Free PMC article.

8

CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.

Hurwitz AA, Yu TF, Leach DR, Allison JP. Hurwitz AA, et al. Among authors: allison jp. Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10067-71. doi: 10.1073/pnas.95.17.10067. Proc Natl Acad Sci U S A. 1998. PMID: 9707601 Free PMC article.

9

A role for CTLA-4-mediated inhibitory signals in peripheral T cell tolerance?

Allison JP, Chambers C, Hurwitz A, Sullivan T, Boitel B, Fournier S, Brunner M, Krummel M. Allison JP, et al. Novartis Found Symp. 1998;215:92-8; discussion 98-102, 186-90. doi: 10.1002/9780470515525.ch7. Novartis Found Symp. 1998. PMID: 9760573 Review.

10

Secondary but not primary T cell responses are enhanced in CTLA-4-deficient CD8+ T cells.

Chambers CA, Sullivan TJ, Truong T, Allison JP. Chambers CA, et al. Among authors: allison jp. Eur J Immunol. 1998 Oct;28(10):3137-43. doi: 10.1002/(SICI)1521-4141(199810)28:10<3137::AID-IMMU3137>3.0.CO;2-X. Eur J Immunol. 1998. PMID: 9808182

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results